Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Conditions

Breast Neoplasms 2232Neoplasms 2038Lung Neoplasms 1096Colorectal Neoplasms 1036Prostatic Neoplasms 894Carcinoma, Non-Small-Cell Lung 752Carcinoma, Hepatocellular 673Stomach Neoplasms 607Pancreatic Neoplasms 602Head and Neck Neoplasms 434Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 346Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 293Urinary Bladder Neoplasms 290Leukemia, Myeloid, Acute 278Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 252Disease 244Recurrence 225Glioma 218Carcinoma, Renal Cell 207

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × Anophthalmia with pulmonary hypoplasia × Clear all
NCT05201729 2022-02-08

Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer

Ruijin Hospital

Unknown
30 enrolled

Anophthalmia with pulmonary hypoplasia

NCT05168254 2021-12-23

Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer

Ruijin Hospital

Unknown
50 enrolled

Anophthalmia with pulmonary hypoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡